Structure Therapeutics Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Structure Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2022 to Q3 2024.
  • Structure Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$34M, a 42.4% decline year-over-year.
  • Structure Therapeutics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$111M, a 43.6% decline year-over-year.
  • Structure Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$89.6M, a 74.6% decline from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$111M -$34M -$10.1M -42.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$100M -$26M -$2.75M -11.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-13
Q1 2024 -$97.7M -$26M -$8.06M -44.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-13
Q4 2023 -$89.6M -$24.5M -$12.6M -106% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-08
Q3 2023 -$77M -$23.9M -$11.4M -92.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$65.5M -$23.3M -$9.33M -66.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-13
Q1 2023 -$56.2M -$18M -$4.89M -37.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-13
Q4 2022 -$51.3M -$11.9M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 -$12.4M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-17
Q2 2022 -$13.9M Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-17
Q1 2022 -$13.1M Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.